Iron oxide-enhanced MR lymphography: initial experience
- 1 June 2000
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 34 (3) , 257-264
- https://doi.org/10.1016/s0720-048x(00)00204-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.American Journal of Roentgenology, 1999
- Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancerJournal of Magnetic Resonance Imaging, 1997
- MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agentJournal of Magnetic Resonance Imaging, 1997
- MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (combidex): Preliminary observationsJournal of Magnetic Resonance Imaging, 1997
- Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administrationMagnetic Resonance Imaging, 1994
- Phase I clinical evaluation of a new iron oxide MR contrast agentJournal of Magnetic Resonance Imaging, 1994
- MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.American Journal of Roentgenology, 1994
- Superparamagnetic iron oxides as positive MR contrast agents: In vitro and in vivo evidenceMagnetic Resonance Imaging, 1993
- MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis.American Journal of Roentgenology, 1992
- Microvascular permeability of normal and neoplastic tissuesMicrovascular Research, 1986